General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 51: Which histopathological type of odontogenic keratocyst is commoner, more invasive, and has a greater tendency for recurrence?

A. Orthokeratinised
B. Parakeratinised (Correct Answer)
C. Non-keratinised
D. Diskeratinised

Explanation: **Explanation:** The **Odontogenic Keratocyst (OKC)** is a unique developmental cyst derived from the dental lamina [1]. Histopathologically, it is categorized based on the type of keratinization of its epithelial lining. **1. Why Parakeratinised is Correct:** The **Parakeratinised** type is the most common variant (approx. 85-90%). It is characterized by a thin, uniform epithelial lining (6–8 cells thick) with a prominent, hyperchromatic **palisaded basal layer** (often described as "tombstone" or "picket-fence" appearance). This variant is clinically significant because it exhibits higher mitotic activity, infiltrative growth into the medullary bone, and a high recurrence rate (up to 30-60%). Its aggressive nature is often linked to mutations in the **PTCH1 gene** [2]. **2. Why Other Options are Incorrect:** * **Orthokeratinised:** Now often classified separately as the *Orthokeratinized Odontogenic Cyst (OOC)*. It features a prominent granular cell layer and lacks the palisaded basal layer. It is significantly less aggressive, rarely recurs, and is usually associated with an impacted tooth. * **Non-keratinised:** This is not a feature of OKC. Non-keratinized linings are typical of other cysts like the Dentigerous cyst or Radicular cyst [1]. * **Diskeratinised:** Dyskeratosis (premature keratinization) is not a defining diagnostic feature for the classification of OKCs. **NEET-PG High-Yield Pearls:** * **Syndromic Association:** Multiple OKCs are a hallmark of **Gorlin-Goltz Syndrome** (Nevoid Basal Cell Carcinoma Syndrome) [2]. * **Radiology:** Typically presents as a well-defined unilocular or multilocular radiolucency, often growing in an **anteroposterior direction** within the mandible without causing significant bone expansion. * **Daughter Cysts:** The presence of "satellite" or "daughter" cysts in the fibrous capsule of the parakeratinized type is a major reason for its high recurrence rate after simple curettage. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, p. 741. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Skin, pp. 1158-1160.

Question 52: Which of the following is found in secondary granules of neutrophils?

A. Catalase
B. Gangliosidase
C. Proteolytic enzyme
D. Lactoferrin (Correct Answer)

Explanation: Explanation: Neutrophils contain two main types of granules: **Primary (Azurophilic)** and **Secondary (Specific)** granules. Understanding their contents is high-yield for NEET-PG. **1. Why Lactoferrin is correct:** Secondary (Specific) granules are smaller and more numerous. They contain **Lactoferrin**, an iron-binding protein that inhibits bacterial growth by sequestering iron. Other key components of secondary granules include Vitamin B12 binding protein, Lysozyme, Collagenase, and Alkaline Phosphatase. **2. Why the other options are incorrect:** * **Catalase:** This is an antioxidant enzyme found in **Peroxisomes**, not in neutrophil granules. It protects cells from oxidative damage by breaking down hydrogen peroxide. * **Gangliosidase (and other Acid Hydrolases):** These are characteristic of **Lysosomes**. While neutrophils have lysosomal activity, specific enzymes like gangliosidase are not the defining markers of secondary granules [1]. * **Proteolytic Enzymes:** While both granules contain enzymes, major proteolytic enzymes like **Myeloperoxidase (MPO)**, Elastase, and Cathepsin G are specifically located in **Primary (Azurophilic) granules** [1]. **Clinical Pearls for NEET-PG:** * **Primary Granules:** Contain Myeloperoxidase (MPO) – the hallmark of the myeloid lineage [1]. * **Secondary Granules:** Contain **Leukocyte Alkaline Phosphatase (LAP)**. The LAP score is decreased in Chronic Myeloid Leukemia (CML) but increased in Leukemoid reactions. * **Tertiary Granules:** Contain Gelatinase and Cathepsins, which aid in tissue degradation and migration. * **Chediak-Higashi Syndrome:** A classic exam topic involving a defect in vesicle fusion, leading to giant granules in neutrophils. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 91-92.

Question 53: Which of the following chromosomal abnormalities is most likely to cause mental retardation?

A. Klinefelter's syndrome
B. Fusion of chromosomes 21 and 15
C. Turner's syndrome
D. Trisomy 21 (Correct Answer)

Explanation: **Explanation:** **Trisomy 21 (Down Syndrome)** is the most common chromosomal cause of intellectual disability (mental retardation) [1]. It occurs due to a non-disjunction event during meiosis, leading to an extra copy of chromosome 21. The overexpression of genes on this chromosome interferes with normal neurodevelopment, resulting in varying degrees of cognitive impairment (typically IQ 25–50) [1]. **Analysis of Incorrect Options:** * **Klinefelter’s Syndrome (47, XXY):** While these individuals may have subtle learning disabilities or speech delays, the majority have a normal range of intelligence. It is primarily a disorder of male hypogonadism and infertility. * **Fusion of chromosomes 21 and 15 (Robertsonian Translocation):** This describes a "balanced carrier" state if no genetic material is lost [3]. While a carrier is at high risk of having a child with Down Syndrome, the individual themselves is phenotypically normal and does not exhibit mental retardation [3]. * **Turner’s Syndrome (45, X):** Most individuals with Turner’s syndrome have normal intelligence. They may exhibit specific deficits in visuospatial processing or mathematics, but they do not typically meet the criteria for mental retardation. **Clinical Pearls for NEET-PG:** * **Most common cause of mental retardation:** Genetic (overall), but specifically **Trisomy 21** (chromosomal) and **Fragile X Syndrome** (inherited/monogenic). * **Down Syndrome Markers:** Associated with early-onset Alzheimer’s disease (due to APP gene on Chr 21) [2], [4], Brushfield spots, and endocardial cushion defects. * **Risk Factor:** Advanced maternal age (>35 years) is the most significant risk factor for meiotic non-disjunction [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 171-172. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 720-721. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 170-171. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1290-1292.

Question 54: What is the inheritance pattern of Familial hypercholesterolemia?

A. Autosomal recessive
B. Autosomal dominant (Correct Answer)
C. X-linked dominant
D. X-linked recessive

Explanation: **Explanation:** **Familial Hypercholesterolemia (FH)** is a classic example of an **Autosomal Dominant (AD)** disorder [1]. It is primarily caused by mutations in the **LDLR gene**, which encodes the Low-Density Lipoprotein (LDL) receptor [1]. 1. **Why Autosomal Dominant is correct:** In FH, a mutation in a single allele (heterozygous state) is sufficient to cause a significant reduction (approx. 50%) in functional LDL receptors [2]. This leads to impaired hepatic clearance of LDL from the plasma, resulting in elevated serum cholesterol levels from birth. The "gene dosage effect" is evident here: heterozygotes have 2–3 times normal cholesterol levels, while rare homozygotes have 5–10 times normal levels [5]. 2. **Why other options are incorrect:** * **Autosomal Recessive:** Most enzyme deficiencies are recessive, but structural proteins or receptors (like LDLR) typically follow a dominant pattern because a 50% reduction in function is clinically symptomatic [2], [4]. * **X-linked (Dominant/Recessive):** The LDLR gene is located on **Chromosome 19**, an autosome. Therefore, the inheritance is not linked to the X or Y sex chromosomes [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Triad:** Hypercholesterolemia, **Tendon Xanthomas** (most commonly on the Achilles tendon), and premature Coronary Artery Disease (CAD). * **Arcus Senilis:** A corneal lipid deposit often seen at a young age in these patients. * **Mutations:** While LDLR is most common, mutations in **APOB** or **PCSK9** genes can also cause AD Familial Hypercholesterolemia. * **Statins** are the first-line treatment as they upregulate the expression of the remaining functional LDL receptors. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 157-159. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 149-150. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 53-54. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 57-58. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, p. 147.

Question 55: Lipofuscin, the golden yellow pigment, is typically seen in which cellular change?

A. Hypertrophy
B. Atrophy (Correct Answer)
C. Hyperplasia
D. Infarction

Explanation: **Explanation:** **Lipofuscin**, often referred to as the "wear-and-tear" or "aging" pigment, is an insoluble brownish-yellow granular intracellular material [1]. It is a hallmark of free radical injury and lipid peroxidation [4]. **1. Why Atrophy is correct:** Lipofuscin is most commonly seen in cells undergoing slow, progressive **atrophy**, particularly in permanent cells like cardiomyocytes and neurons [1]. As a cell atrophies, it undergoes autophagic digestion of its own organelles [2]. Lipofuscin represents the undigested residues of these autophagic vacuoles (peroxidized polyunsaturated lipids of subcellular membranes) [4]. When extensive atrophy occurs in an organ (like the heart) alongside heavy lipofuscin accumulation, it is clinically termed **"Brown Atrophy."** [3] **2. Why other options are incorrect:** * **Hypertrophy & Hyperplasia:** These are adaptive responses characterized by an *increase* in cell size or number, respectively [3], usually due to increased functional demand or hormonal stimulation. They are not primarily associated with the degradative processes that produce lipofuscin. * **Infarction:** This refers to localized area of ischemic necrosis. While cell injury occurs, the acute nature of infarction leads to coagulative necrosis rather than the chronic, progressive accumulation of lipofuscin. **High-Yield NEET-PG Pearls:** * **Composition:** Lipofuscin is a complex of lipids and proteins (lipoprotein). * **Staining:** It is **PAS positive** and can be visualized with Sudan Black B. * **Key Distinction:** Unlike hemosiderin (which is also golden-brown), lipofuscin is **Perls' Prussian Blue negative** (contains no iron). * **Clinical Significance:** It is not toxic to the cell itself but serves as a "telltale sign" of past free radical damage and cellular aging [4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 75. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 71-73. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 47-49. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 241-242.

Question 56: Type I hypersensitivity is mediated by which of the following immunoglobulins?

A. IgA
B. IgG
C. IgM
D. IgE (Correct Answer)

Explanation: **Explanation:** **Type I Hypersensitivity**, also known as **Immediate Hypersensitivity**, is primarily mediated by **IgE antibodies** [1]. The process begins when an allergen triggers B-cells to undergo class-switching to produce IgE. These IgE molecules bind to high-affinity receptors (FcεRI) on the surface of **mast cells and basophils** [2]. Upon re-exposure, the allergen crosses-links the bound IgE, triggering degranulation and the release of vasoactive amines like histamine, leading to rapid clinical manifestations [4]. **Analysis of Options:** * **IgE (Correct):** It is the hallmark of Type I reactions, involved in allergic rhinitis, asthma, and anaphylaxis [3]. * **IgG & IgM (Incorrect):** These are the primary mediators of **Type II** (Cytotoxic) and **Type III** (Immune-complex mediated) hypersensitivity [1]. IgG is also involved in opsonization and secondary immune responses. * **IgA (Incorrect):** This is the primary immunoglobulin of mucosal immunity (secretory IgA) and is not a mediator of hypersensitivity reactions. **NEET-PG High-Yield Pearls:** * **Gell and Coombs Classification:** Remember the mnemonic **ACID** (Type I: **A**naphylactic/Atopic; Type II: **C**ytotoxic; Type III: **I**mmune Complex; Type IV: **D**elayed/Cell-mediated) [1]. * **Cells Involved:** Mast cells are the central effector cells in Type I; Eosinophils are recruited during the "late-phase" response [4]. * **Th2 Cells:** Type I reactions are driven by Th2 cells which secrete **IL-4** (stimulates IgE production) and **IL-5** (activates eosinophils) [1]. * **Common Examples:** Urticaria, Atopic dermatitis, Bronchial asthma, and Anaphylactic shock [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 208-210. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 210-211. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 171-172. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 211-212.

Question 57: von Willebrand disease is a defect of which process in hemostasis?

A. Primary hemostasis (Correct Answer)
B. Secondary hemostasis
C. Clot stabilization and resorption
D. Generalized defects involving small vessels

Explanation: **Explanation:** **von Willebrand Disease (vWD)** is the most common inherited bleeding disorder [2]. It is characterized by a quantitative or qualitative deficiency of **von Willebrand Factor (vWF)**, which plays a critical role in **primary hemostasis** [2]. 1. **Why Option A is correct:** Primary hemostasis involves the formation of a platelet plug [3]. vWF acts as a molecular bridge between the subendothelial collagen and the **GpIb receptor** on platelets (platelet adhesion) [1], [2]. Without functional vWF, platelets cannot adhere to the site of vascular injury, leading to a defect in the initial platelet plug formation. 2. **Why other options are incorrect:** * **Secondary hemostasis (B):** This involves the coagulation cascade and fibrin formation. While vWF does stabilize Factor VIII, the hallmark clinical presentation of vWD (mucocutaneous bleeding) is primarily due to the platelet adhesion defect [2]. * **Clot stabilization (C):** This is mediated by Factor XIII and the fibrinolytic system (plasmin), which are not primarily affected in vWD [1]. * **Small vessel defects (D):** These refer to vascular purpuras (e.g., Henoch-Schönlein purpura or Vitamin C deficiency), where the pathology lies in the vessel wall itself, not the clotting factors or platelets [4]. **High-Yield Clinical Pearls for NEET-PG:** * **Inheritance:** Most types are Autosomal Dominant (Type 1 is most common). * **Lab Findings:** Increased Bleeding Time (BT) and often an increased aPTT (due to low Factor VIII levels). Platelet count is usually normal. * **Diagnostic Test:** Ristocetin Cofactor Assay (measures vWF-induced platelet agglutination). * **Treatment:** Desmopressin (DDAVP), which releases vWF from Weibel-Palade bodies in endothelial cells. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 128. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 669-670. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 581-582. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 619-620.

Question 58: Necrotizing epithelioid cell granulomas are seen in all of the following conditions, except?

A. Tuberculosis
B. Wegener's granulomatosis
C. Cat's Scratch disease
D. Leprosy (Correct Answer)

Explanation: ### Explanation The key to this question lies in distinguishing between **necrotizing (caseating)** and **non-necrotizing** granulomas. **1. Why Leprosy is the Correct Answer:** In Leprosy (Hansen’s disease), the granulomas are typically **non-necrotizing**. * In **Tuberculoid Leprosy (TT)**, well-formed epithelioid cell granulomas are seen, but they do not undergo central caseous necrosis. [1] * In **Lepromatous Leprosy (LL)**, there are no true granulomas; instead, there are diffuse collections of "foamy macrophages" (Virchow cells) packed with acid-fast bacilli. Therefore, necrotizing granulomas are not a feature of Leprosy. **2. Analysis of Incorrect Options:** * **Tuberculosis (A):** The hallmark of TB is the **caseating (necrotizing) granuloma**. The central area of "cheesy" necrosis is surrounded by epithelioid cells, Langhans giant cells, and a peripheral rim of lymphocytes. * **Wegener’s Granulomatosis (B):** Now known as Granulomatosis with Polyangiitis (GPA), it is characterized by a triad of necrotizing granulomas of the respiratory tract, necrotizing vasculitis, and focal necrotizing glomerulonephritis. The necrosis is often described as **"geographic necrosis."** * **Cat Scratch Disease (C):** This condition typically presents with **stellate (star-shaped) necrotizing granulomas** in the lymph nodes, often containing central debris and neutrophils. **3. NEET-PG High-Yield Pearls:** * **Non-necrotizing granulomas:** Sarcoidosis (classic), Berylliosis, Tuberculoid Leprosy, and Crohn’s disease. [2], [3] * **Asteroid bodies & Schaumann bodies:** High-yield inclusions seen in Sarcoidosis. * **Gummatous Necrosis:** Specific to Tertiary Syphilis. * **Fibrinoid Necrosis:** Seen in Immunological injuries (e.g., PAN, Rheumatic nodules, Malignant hypertension). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 109. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 700-701. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 198-200.

Question 59: All of the following are examples of microdeletion syndromes, EXCEPT:

A. Wilms' tumor-aniridia complex
B. Miller Dieker syndrome
C. Velocardiofacial syndrome
D. None of the above (Correct Answer)

Explanation: ### Explanation The correct answer is **None of the above** because all three conditions listed (Options A, B, and C) are classic examples of **Microdeletion Syndromes**. **Microdeletion syndromes** (also known as contiguous gene syndromes) occur due to the loss of a small chromosomal segment (usually <5Mb) involving several adjacent genes. These deletions are often too small to be detected by standard high-resolution karyotyping and typically require **Fluorescence In Situ Hybridization (FISH)** or chromosomal microarray for diagnosis [1]. #### Analysis of Options: * **Wilms’ tumor-aniridia complex (WAGR Syndrome):** This is caused by a microdeletion at **11p13**. The acronym WAGR stands for Wilms’ tumor, Aniridia, Genitourinary anomalies, and Retardation (intellectual disability). It involves the *WT1* and *PAX6* genes. * **Miller-Dieker Syndrome:** This results from a microdeletion at **17p13.3**. It is clinically characterized by **lissencephaly** (smooth brain), severe intellectual disability, and distinct facial features. * **Velocardiofacial Syndrome (Shprintzen Syndrome):** This is part of the **22q11.2 deletion** spectrum (which also includes DiGeorge Syndrome) [1]. Clinical features include cleft palate, cardiac defects (like Tetralogy of Fallot), and learning disabilities [1]. #### NEET-PG High-Yield Pearls: 1. **Diagnosis:** FISH is the gold standard for rapid diagnosis of microdeletions [1]. 2. **Prader-Willi & Angelman Syndromes:** These are the most frequently tested microdeletion syndromes, both involving **15q11-q13** [2]. They demonstrate **genomic imprinting** (Prader-Willi is paternal deletion; Angelman is maternal deletion) [2]. 3. **Cri-du-chat Syndrome:** Caused by a deletion on the short arm of chromosome 5 (**5p-**). 4. **Williams Syndrome:** Caused by a microdeletion at **7q11.23** (includes the elastin gene), characterized by "elfin" facies and "cocktail party" personality. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 172-173. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 181-183.

Question 60: Ehlers-Danlos syndrome is a disease affecting which of the following?

A. Bone
B. Connective tissue (Correct Answer)
C. Muscle
D. Joints

Explanation: **Explanation:** **Ehlers-Danlos Syndrome (EDS)** is a heterogeneous group of heritable disorders characterized by defects in the synthesis or structure of **fibrillar collagen** [1]. Since collagen is the primary structural protein of the extracellular matrix, EDS fundamentally affects **connective tissue** throughout the body [1]. **Why Connective Tissue is Correct:** The underlying pathology involves mutations in genes encoding collagen (e.g., Type I, III, or V) or enzymes responsible for post-translational modifications (e.g., lysyl hydroxylase) [1]. This results in tissues lacking tensile strength, leading to the classic triad of **skin hyperextensibility, joint hypermobility, and tissue fragility.** [1] **Why Other Options are Incorrect:** * **Bone:** While some types of EDS (like the Kyphoscoliotic type) involve skeletal deformities, the primary defect is in the soft connective tissue matrix, not the bone mineralization process (unlike Osteogenesis Imperfecta). * **Muscle:** EDS does not primarily affect muscle fibers or the neuromuscular junction; any perceived weakness is usually secondary to joint instability. * **Joints:** While joint hypermobility is a hallmark clinical sign, the "joint" itself is a complex structure. The disease affects the **ligaments and tendons** [1] (connective tissues) that support the joint, rather than the joint space or cartilage primarily. **High-Yield Clinical Pearls for NEET-PG:** * **Classical Type:** Mutation in **Type V Collagen** (COL5A1, COL5A2); features skin fragility and "cigarette paper" (atrophic) scars. * **Vascular Type:** Mutation in **Type III Collagen** (COL3A1); most serious form due to risk of **rupture of large arteries** [1] or the colon. * **Kyphoscoliotic Type:** Deficiency of **lysyl hydroxylase**; characterized by hypotonia and progressive scoliosis. * **Inheritance:** Most types are Autosomal Dominant, but the Kyphoscoliotic type is Autosomal Recessive. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 154-156.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free